3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Renal Cell
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Myelodysplastic Syndromes
4
Lung Neoplasms
4
Clear-cell metastatic renal cell carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Endometrioid
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Paclitaxel
24
Bevacizumab
21
Carboplatin
20
liposomal doxorubicin
15
Specimen Handling
14
olaparib
13
Magnetic Resonance Spectroscopy
13
Gemcitabine
10
Topotecan
9
pembrolizumab
8
Biopsy
8
Taxes
7
Immunoglobulin G
6
Disulfides
6
niraparib
5
Doxorubicin
5
mirvetuximab soravtansine
4
cediranib
4
oregovomab
3
Nivolumab
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Cisplatin
3
sarilumab
2
rucaparib
2
cemiplimab
2
berzosertib
2
adavosertib
2
Saline Solution
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
CTLA-4 Antigen
×
90 days
×
Clear all
No trials found.